Loading...
Eurobio Scientific SA
ALERS.PA•EURONEXT
Healthcare
Medical - Devices
€25.40
€0.00(0.00%)
Eurobio Scientific SA (ALERS.PA) Financial Performance & Income Statement Overview
Review Eurobio Scientific SA’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
18.60%
↑ 18.60%
Operating Income Growth
32.14%
↑ 32.14%
Net Income Growth
-17.27%
↓ 17.27%
Operating Cash Flow Growth
-37.60%
↓ 37.60%
Operating Margin
9.97%
↑ 9.97%
Gross Margin
45.06%
↑ 45.06%
Net Profit Margin
2.58%
↑ 2.58%
ROE
2.24%
↑ 2.24%
ROIC
7.26%
↑ 7.26%
Eurobio Scientific SA (ALERS.PA) Income Statement & Financial Overview
Review Eurobio Scientific SA's (ALERS.PA) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $81.63M | $73.45M | $71.27M | $59.16M |
| Cost of Revenue | $45.10M | $40.10M | $40.60M | $35.48M |
| Gross Profit | $36.53M | $33.35M | $30.67M | $23.67M |
| Gross Profit Ratio | $0.45 | $0.45 | $0.43 | $0.40 |
| R&D Expenses | $1.88M | $4.23M | $4.14M | $2.88M |
| SG&A Expenses | $26.007M | $19.49M | $20.33M | $13.20M |
| Operating Expenses | $27.89M | $26.52M | $25.10M | $19.60M |
| Total Costs & Expenses | -$72.99M | $66.62M | $65.70M | $55.09M |
| Interest Income | $0.00 | $0.00 | $0.00 | $1.74M |
| Interest Expense | $0.00 | $2.15M | $0.00 | $2.26M |
| Depreciation & Amortization | $1.92M | $4.66M | $6.15M | $5.56M |
| EBITDA | $8.19M | $11.49M | $12.22M | $9.63M |
| EBITDA Ratio | $0.10 | $0.16 | $0.17 | $0.16 |
| Operating Income | $8.64M | $6.83M | $6.07M | $4.07M |
| Operating Income Ratio | $0.11 | $0.09 | $0.09 | $0.07 |
| Other Income/Expenses (Net) | -$8.23M | -$938000.00 | -$2.00M | -$1.17M |
| Income Before Tax | $409000.00 | $5.89M | $4.07M | $2.90M |
| Income Before Tax Ratio | $0.005 | $0.08 | $0.06 | $0.05 |
| Income Tax Expense | $408000.00 | $1.89M | $1.43M | $712000.00 |
| Net Income | $1000.00 | $4.00M | $2.64M | $2.19M |
| Net Income Ratio | $0.00 | $0.05 | $0.04 | $0.04 |
| EPS | $0.00 | $0.40 | $0.29 | $0.21 |
| Diluted EPS | $0.00 | $0.40 | $0.29 | $0.21 |
| Weighted Avg Shares Outstanding | $10.25M | $10.03M | $9.16M | $10.21M |
| Weighted Avg Shares Outstanding (Diluted) | $10.25M | $10.03M | $0.00 | $10.21M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan